52
Participants
Start Date
July 28, 2019
Primary Completion Date
October 14, 2019
Study Completion Date
April 17, 2020
Danicopan
Danicopan was dosed as 2 x 100 milligram (mg) tablets.
Warfarin
Warfarin was dosed as 2 x 10 mg and 1 x 5 mg warfarin sodium tablets (Coumadin or generic equivalent).
Bupropion
Bupropion was dosed as Wellbutrin (or generic equivalent) as 1 x 100 mg tablet.
Ethinyl Estradiol/Norethindrone
EE/NET (0.035 mg/1 mg) was dosed as Ortho-Novum-1/35 (or generic equivalent) fixed-dose combination tablets.
Clinical Study Site, Tempe
Lead Sponsor
Collaborators (1)
Achillion, a wholly owned subsidiary of Alexion
INDUSTRY
Celerion
INDUSTRY
Alexion Pharmaceuticals, Inc.
INDUSTRY